Diagnostics

Foundation for Neglected Disease Research

  • Program
  • Pre Clinical
  • Clinical
FNDR is the recipient of a grant award: Grand challenges in Tuberculosis (GC-TBC) entitled “Diagnosis of Tuberculosis using host and bacterial biomarker signatures”. This is funded by United States Agency for International Development (USAID), Biotechnology Industrial Research Assistance Council (BIRAC) and Bill and Melinda Gates Foundation (BMGF), and implemented by ICICI Knowledge Park (IKP) Hyderabad. FNDR also holds complete rights to a patent that has been filed for a biomarker based diagnostic for detection of TB (Itaconic acid and Tuberculostearic acid)
FNDR holds a patent for azo dyes that can be used to the detection and/or quantification of itaconic acid for the diagnosis of gestational diabetes mellitus and preterm labour and also methods of using the azo dyes to react with itaconic acid and methods of using the product of the reaction between the azo dyes and itaconic acid, to detect quantify itaconic acid in samples of interest. This is currently under the clinical stage.
FNDR was awarded the NESTA-Longitude Prize under BIRAC Discovery award funding for the project – Biomarker based diagnostic to differentiate between bacterial and viral infections